Latest News
- July 03, 2025Successful completion of an unannounced USFDA inspection
- June 30, 2025Successful completion of 2 USFDA inspections with ZERO 483 in June 2025
- June 24, 2025Two USFDA inspections in ophthalmology, with ZERO 483
- June 17, 2025CBCC Brings the Community Together at BIO 2025!
- June 05, 2025Join CBCC at CPHI China 2025
Attending The 42nd Annual J. P. Morgan Healthcare Conference
Manoj Vyas (CEO – CBCC Global Research) will be attending The 42nd Annual J. P. Morgan Healthcare Conference, the largest and most informative healthcare investment symposium in the industry, during 8 – 11 January 2024, at San Francisco, CA.
For more information on this conference, please visit: https://lnkd.in/eZBPTdbM
For business appointments please email us at: manoj.vyas@cbcc.global
We will be attending below upcoming events:
1. The 42nd Annual J. P. Morgan Healthcare Conference (8 – 11 January 2024, San Francisco, California)
2. Bio Asia 2024 (26 – 28 February 2024, Hyderabad, India)
3. Immuno-Oncology 360 (27 – 29 February 2024, New York)
4. DCAT Week (18 – 21 March 2024, New York)
We will be glad to schedule an appointment with you to discuss your upcoming drug development plan and help you bring the treatment to market faster.
CBCC Global Research: CHANGING LIVES THROUGH HOPE AND INNOVATION